September 23, 2024
AstraZeneca’s FluMist vaccine won FDA approval late last week for at-home administration, making it the first “take-out” flu vaccine that doesn’t need to be administered by a healthcare provider.
September 23, 2024
AstraZeneca’s FluMist vaccine won FDA approval late last week for at-home administration, making it the first “take-out” flu vaccine that doesn’t need to be administered by a healthcare provider.